banner
Reference Listed Drugs
ERLEADA 60mg Apalutamide Tablets Reference Listed Drug

ERLEADA 60mg Apalutamide Tablets Reference Listed Drug

ERLEADA is indicated for the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC) in adult patients at high risk of metastasis. For R&D purposes only.

Product Details

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

 

Generic name Apalutamide Tablets
Trade name ERLEADA
Specification 60mg
Main ingredients Apalutamide
Appearance

This product is pale yellowish green to grayish green oval film coated with "AR60\" inscribed on one side.

After removing the coating, it appears white to white or yellowish.

MA Holder Janssen-Cilag International NV
Manufacturer Janssen Ortho, LLC
Product Type Reference Listed Drug

 

 

 

Indications: ERLEADA is indicated for the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC) in adult patients at high risk of metastasis.

 

 

 

 

ERLEADA-1

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

Hot Tags: ERLEADA 60mg Apalutamide Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Olanzapine Tablets, Argatroban Injection, Reference Listed Drugs, Esomeprazole Magnesium Enteric Coated Capsules, Agomelatine Tablets, Adefovir Dipivoxil Tablets

Send Inquiry
Verification Code: